Search all medical codes

Injection, butorphanol tartrate, 1 mg

HCPCS code

Name of the Procedure:

Injection, butorphanol tartrate, 1 mg

Common names: Butorphanol injection, Stadol injection Technical terms: Butorphanol tartrate injection

Summary

This procedure involves the administration of butorphanol tartrate, a medication used for pain relief. It is delivered via an injection, typically into muscle tissue or intravenously.

Purpose

Medical conditions addressed: Severe pain management, often related to surgery, injury, or migraines. Goals: Rapid and effective relief from acute or chronic pain.

Indications

Symptoms: Intense, acute pain; moderate to severe chronic pain conditions. Patient criteria: Adults experiencing severe pain unrelieved by other analgesics, patients needing short-term pain control, or those intolerant or allergic to other pain medications.

Preparation

Pre-procedure instructions: Generally, no extensive preparation is needed. Patients should inform their doctor of all medications they are taking and any history of allergies or reactions to pain medications. Diagnostic tests: No specific tests required; medical history and a physical examination generally suffice.

Procedure Description

  1. The healthcare professional will clean the injection site with antiseptic.
  2. Using a sterile needle and syringe, they will draw up the correct dosage (1 mg) of butorphanol tartrate.
  3. The medication is then injected into a muscle (intramuscular) or directly into a vein (intravenous).
  4. Patients are monitored for any immediate reactions.

Tools: Syringe, sterile needle, antiseptic wipes. Anesthesia or Sedation: Typically, no anesthesia or sedation, but local anesthesia may be applied in some cases for patient comfort.

Duration

The actual injection takes just a few minutes, although monitoring for adverse reactions may take an additional 15-30 minutes.

Setting

Location: The procedure is usually done in a hospital, outpatient clinic, or doctor's office.

Personnel

Healthcare professionals involved: Doctor, nurse, or trained medical technician.

Risks and Complications

Common risks: Nausea, dizziness, drowsiness, headache. Rare risks: Respiratory depression, allergic reactions, confusion, hallucinations. Management: Close monitoring and, if necessary, administration of antidotes or supportive treatments.

Benefits

Expected benefits: Quick and effective pain relief, often within 15-20 minutes post-injection. How soon benefits are realized: Almost immediately for IV administration, within 15-30 minutes for intramuscular injections.

Recovery

Post-procedure care: Patients are generally advised to rest for a short period after the injection. Expected recovery time: No downtime required for recovery from the injection itself; however, the duration of pain relief varies and may require repeated doses. Restrictions and follow-up: Patients should follow up with their healthcare provider if pain persists or adverse effects occur.

Alternatives

Other treatment options: Oral pain medications, other opioid injections (e.g., morphine), non-opioid pain relievers, physical therapy. Pros and cons: Oral medications are less invasive but may take longer to work. Non-opioid alternatives may have fewer risks but might not provide sufficient pain relief.

Patient Experience

During the procedure: The patient might feel a brief sting at the injection site. After the procedure: Possible side effects include feeling drowsy or lightheaded. Pain relief typically begins shortly after the injection for IV administration and within 15-30 minutes for intramuscular. Pain management and comfort measures: Patients can discuss any discomfort or side effect concerns with their healthcare provider, who can offer measures such as hydration, rest, or additional medications to manage side effects.


Similar Codes